Onyx Biotec Ltd. has announced a Compliance Certificate for its Structured Digital Database, confirming secure management and controlled access to unpublished price-sensitive information (UPSI) with records kept for eight years. During the period, one event was recorded in the database. This highlights the company’s strong internal controls on sensitive information, supporting governance and transparency, which is important for investor confidence.